Induction of T-cell Proliferation by Recombinant Mouse and Chimeric Mouse/human Anti-CD3 Monoclonal Antibodies
Overview
Authors
Affiliations
The isotype of anti-CD3 mAb has a dramatic effect on anti-CD3 induced T-cell activation, as was previously reported for switch variants (IgG2b to IgA) of a high-avidity IgG1 anti-CD3 mAb (CLB-T3/4.1). In order to study and compare the isotype dependency of T-cell activation with anti-CD3 mAb of various mouse and human subclasses, we now prepared recombinant anti-CD3 mAb. The variable region of the anti-CD3 Ig heavy chain was cloned, joined with genes for the heavy chain constant region and expressed in a cell line only secreting autologous mouse chi light chains. Thus we obtained cell lines that produced mouse (m) IgM, mIgG3 and chimaeric mouse/human (h) IgM, hlgG1, hlgG2, hlgG3, hlgG4, hlgE and hlgA2 anti-CD3. The matched set of mouse and mouse/human chimaeric anti-CD3 isotypes switch variants was then used to study activation of T cells in an accessory cell-dependent system. hlgG1, hlgG4, hlgE, mlgG2a and mlgE induced T-cell proliferation in PBMC of all donors tested, whereas PBMC from a subset of donors were unresponsive to stimulation with hlgG2, hlgG3, hlgA2, mlgG1 and mlgG2b anti-CD3 mAb. hlgM, mlgM and mlgA were only able to induce T-cell mitogenesis in combination with PMA. Our panel of anti-CD3 mAb variants may prove a powerful tool to study mouse and human isotype-dependent effector functions and their influence on T-cell activation requirements in detail.
Logic-gated antibody pairs that selectively act on cells co-expressing two antigens.
Oostindie S, Rinaldi D, Zom G, Wester M, Paulet D, Al-Tamimi K Nat Biotechnol. 2022; 40(10):1509-1519.
PMID: 35879362 PMC: 9546771. DOI: 10.1038/s41587-022-01384-1.
T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv.
Zhong K, Liu Z, Li H, Zhao S, Wang Y, Guo W Aging (Albany NY). 2020; 12(11):11061-11070.
PMID: 32526703 PMC: 7346064. DOI: 10.18632/aging.103318.
Nishiya C, Boxx G, Robison K, Itatani C, Kozel T, Zhang M Infect Immun. 2015; 84(2):386-94.
PMID: 26573736 PMC: 4730579. DOI: 10.1128/IAI.00890-15.
Characterization of a surrogate murine antibody to model anti-human CD3 therapies.
Depis F, Hatterer E, Ballet R, Daubeuf B, Cons L, Glatt S MAbs. 2013; 5(4):555-64.
PMID: 23751612 PMC: 3906309. DOI: 10.4161/mabs.24736.
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Meijer R, Surachno S, Yong S, Bemelman F, Florquin S, ten Berge I Clin Exp Immunol. 2003; 133(3):485-92.
PMID: 12930378 PMC: 1808785. DOI: 10.1046/j.1365-2249.2003.02200.x.